Observational studyMedicine2026
Do pleural fluid pH and lactate improve classification beyond Light's criteria?: A single-center retrospective study.
Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate differentiation between transudative and exudative pleural effusions is essential for determining the underlying etiology and guiding management. Although Light's criteria remain the standard diagnostic approach, their performance may be limited in borderline cases. Biochemical markers such as pleural fluid pH and lactate have been proposed as adjunct tools, yet the extent to which they provide additional diagnostic improvement beyond Light's criteria remains unclear. This single-center retrospective study specifically evaluated whether adding pleural fluid pH and lactate to Light's criteria improves the ability to distinguish transudative from exudative pleural effusions, quantifying the additional diagnostic value of these markers. We retrospectively analyzed 281 patients who underwent diagnostic thoracentesis between November 2020 and March 2024. Receiver operating characteristic-derived cutoff values and corresponding area under the curve (AUC)s for pH and lactate were generated and assessed within the same cohort. Multivariable logistic regression models incorporating Light's criteria alone and in combination with pH and/or lactate were constructed to assess incremental discrimination (ΔAUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Of the 281 patients, 62 (22.1%) had transudative and 219 (77.9%) had exudative effusions. Pleural fluid pH ≤ 7.44 showed an AUC of 0.767 (95% CI, 0.696-0.839), sensitivity 71.4%, and specificity 70.2%. Lactate ≥ 2.05 mmol/L yielded an AUC of 0.701 (95% CI, 0.627-0.775), sensitivity 61.7%, and specificity 63.2%. Adding pH to Light's criteria increased diagnostic accuracy (Model-2 AUC 0.985; ΔAUC + 0.010; NRI 0.904; IDI 0.035). Lactate also improved discrimination, though to a lesser extent (Model-3 AUC 0.982; ΔAUC + 0.007; NRI 0.607; IDI 0.025). Incorporating both biomarkers provided the highest incremental metrics (AUC 0.986; ΔAUC + 0.011; IDI 0.053), demonstrating a modest additive benefit across models. Pleural fluid pH and lactate, when added to Light's criteria, provide distinct yet modest incremental gains in diagnostic performance. These findings clarify their potential as an adjunct, though further external validation is necessary before routine clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.